施贵宝（Bristol-Myers Squibb）第二季度业绩显著超出市场预期。该公司报告称，当季调整后每股收益达到2.04美元，而IBES预估仅为1.59美元，表现强劲。
营收方面同样亮眼。施贵宝第二季度实现营收129.7亿美元，大幅超越IBES预测的117.5亿美元。
放眼全年，公司对前景持乐观态度。施贵宝预计，2026财年调整后每股收益将在6.75至7美元区间，显著高于IBES预估的6.34美元。
值得注意的是，公司核心产品阿哌沙班（Eliquis）的营收增长预期也得到大幅上调。施贵宝现预计该产品全年营收增幅将达20%至25%，远超此前10%至15%的预测水平。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.